BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38147886)

  • 1. Psychotropic Medication and Psychosocial Service Use Among Transition Age Youth With Autism Spectrum Disorder.
    Plourde ER; Ali MM; West KD
    Am J Intellect Dev Disabil; 2024 Jan; 129(1):1-9. PubMed ID: 38147886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States.
    Esler A; Hewitt A; Hall-Lande J; Pettingell SL; Houseworth J
    J Autism Dev Disord; 2019 Jun; 49(6):2291-2303. PubMed ID: 30706350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medication use among adolescents and young adults with an autism spectrum disorder: parent views about medication use and healthcare services.
    Lake JK; Vogan V; Sawyer A; Weiss JA; Lunsky Y
    J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):260-8. PubMed ID: 25803636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication Use in Youth With Autism and Attention-Deficit/Hyperactivity Disorder.
    Rast JE; Anderson KA; Roux AM; Shattuck PT
    Acad Pediatr; 2021 Mar; 21(2):272-279. PubMed ID: 32492579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children.
    Rasmussen L; Pratt N; Roughead E; Moffat A
    J Autism Dev Disord; 2019 Jan; 49(1):227-235. PubMed ID: 30136113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic Medication Prescribing for Neuropsychiatric Comorbidities in Individuals Diagnosed with Autism Spectrum Disorder (ASD) in the UK.
    Alfageh BH; Man KKC; Besag FMC; Alhawassi TM; Wong ICK; Brauer R
    J Autism Dev Disord; 2020 Feb; 50(2):625-633. PubMed ID: 31724119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Patterns of State Vocational Rehabilitation Performance in Serving Transition-Age Youth on the Autism Spectrum.
    Roux AM; Rast JE; Nye-Lengerman K; Purtle J; Lello A; Shattuck PT
    Autism Adulthood; 2019 Jun; 1(2):101-111. PubMed ID: 36601530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Many Young Children with Autism Who Use Psychotropic Medication Do Not Receive Behavior Therapy: A Multisite Case-Control Study.
    Wiggins LD; Nadler C; Rosenberg S; Moody E; Reyes N; Reynolds A; Alexander A; Daniels J; Thomas K; Giarelli E; Levy SE
    J Pediatr; 2021 May; 232():264-271. PubMed ID: 33493493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic Medication Use by Children with Autism Served in Publicly Funded Mental Health Settings.
    Caplan B; Chlebowski C; May G; Baker-Ericzén MJ; Connor W; Brookman-Frazee L
    J Dev Behav Pediatr; 2022 Jun-Jul 01; 43(5):252-261. PubMed ID: 34855690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.
    Wink LK; Pedapati EV; Adams R; Erickson CA; Pedersen KA; Morrow EM; Kaplan D; Siegel M;
    J Autism Dev Disord; 2018 Nov; 48(11):3711-3719. PubMed ID: 28516426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and predictors of psychotropic medication use in adolescents and adults with autism spectrum disorder in Italy: A cross-sectional study.
    Fusar-Poli L; Brondino N; Rocchetti M; Petrosino B; Arillotta D; Damiani S; Provenzani U; Petrosino C; Aguglia E; Politi P
    Psychiatry Res; 2019 Jun; 276():203-209. PubMed ID: 31102885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare service utilization and cost among transition-age youth with autism spectrum disorder and other special healthcare needs.
    Ames JL; Massolo ML; Davignon MN; Qian Y; Croen LA
    Autism; 2021 Apr; 25(3):705-718. PubMed ID: 32583679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.
    Logan SL; Carpenter L; Leslie RS; Garrett-Mayer E; Hunt KJ; Charles J; Nicholas JS
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):323-36. PubMed ID: 25919445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Primary Care Providers' Consultations With a Statewide Child Psychiatry Access Program Regarding Autism Spectrum Disorder.
    Reinblatt SP; Coble K; Williams JL; Cotton AM; Bettencourt AF
    J Acad Consult Liaison Psychiatry; 2022; 63(5):463-473. PubMed ID: 35085823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Transition from Child and Adolescent Mental Health Services (CAMHS) To Adult Mental Health Services (AMHS): What about Autism Spectrum Disorder?
    Reis J; Marchini S; Delvenne V
    Psychiatr Danub; 2021 Dec; 33(Suppl 11):52-57. PubMed ID: 34862893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-occurring obsessive-compulsive disorder and autism spectrum disorder in young people: prevalence, clinical characteristics and outcomes.
    Martin AF; Jassi A; Cullen AE; Broadbent M; Downs J; Krebs G
    Eur Child Adolesc Psychiatry; 2020 Nov; 29(11):1603-1611. PubMed ID: 32008168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.
    Jobski K; Höfer J; Hoffmann F; Bachmann C
    Acta Psychiatr Scand; 2017 Jan; 135(1):8-28. PubMed ID: 27624381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.